Replimune Group, Inc.
REPL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737953
In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Replimune Group, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 144 | 1 | 157 | +14 |
| Shares | 69.9M | 450.0K | 77.9M | +8.38M (+12.1%) |
| Value | $766.7M | $4.93M | $943.2M | +$181.5M (+23.8%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (34)
Institutions that held Replimune Group, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (20)
Institutions that held Replimune Group, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Boxer Capital, LLC | 1,536,341 | $16.8M |
| ExodusPoint Capital Management, LP | 422,914 | $4.63M |
| Norges Bank | 379,400 | $4.16M |
| LMR Partners LLP | 82,479 | $904.0K |
| Arizona PSPRS Trust | 76,100 | $834.1K |
| Jacobs Levy Equity Management, Inc | 39,521 | $433.1K |
| Engineers Gate Manager LP | 29,669 | $325.2K |
| Bayesian Capital Management, LP | 23,975 | $262.8K |
| Tudor Investment Corp Et Al | 20,716 | $227.0K |
| Gsa Capital Partners LLP | 20,254 | $222.0K |
| First Trust Advisors LP | 19,849 | $217.5K |
| Fox Run Management, L.L.C. | 12,903 | $141.4K |
| Cornercap Investment Counsel Inc | 12,167 | $133.3K |
| Entropy Technologies, LP | 11,493 | $126.0K |
| Group One Trading, L.P. | 4,339 | $47.6K |
| Amundi | 2,513 | $29.5K |
| nVerses Capital, LLC | 1,300 | $14.2K |
| Simplex Trading, LLC | 1,279 | $14.0K |
| Wolff Wiese Magana LLC | 100 | $1.10K |
| Capital Performance Advisors LLP | 76 | $833 |
Not filed for Q4 2024 yet (1)
Institutions that held Replimune Group, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Ghost Tree Capital, LLC | 450,000 | $4.93M |